Literature DB >> 15563701

Expression of ErbB receptors and mucins in the airways of long term current smokers.

R A O'Donnell1, A Richter, J Ward, G Angco, A Mehta, K Rousseau, D M Swallow, S T Holgate, R Djukanovic, D E Davies, S J Wilson.   

Abstract

BACKGROUND: Airway epithelial goblet cell hyperplasia is known to occur in chronic smokers. Although the epidermal growth factor receptor has been implicated in this process, neither ErbB receptor expression nor the mucosecretory phenotype of the epithelium have been characterised in current smokers.
METHODS: Bronchial biopsies obtained from non-smokers (n = 10) and current smokers, with or without chronic obstructive pulmonary disease (n = 51), were examined immunohistochemically to measure the expression of epidermal growth factor receptor, ErbB2, ErbB3, ErbB4 and mucin subtypes (MUC2, MUC5AC and MUC5B) in the bronchial epithelium. The results were correlated with neutrophil counts measured in the airway wall and induced sputum.
RESULTS: Epidermal growth factor receptor, ErbB3 and MUC5AC expression, in addition to PAS staining, were significantly increased in all smokers compared with non-smokers, irrespective of the presence of chronic obstructive pulmonary disease. MUC5AC expression was significantly associated with both PAS staining and ErbB3 expression; no correlation was observed between either mucin or ErbB receptor expression and neutrophil counts.
CONCLUSIONS: The results suggest that long term current smoking induces enhanced epidermal growth factor receptor, ErbB3, and MUC5AC expression in vivo; these increases are not associated with the presence of neutrophilic inflammation. ErbB receptors may contribute to epithelial responses to cigarette smoke.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15563701      PMCID: PMC1746902          DOI: 10.1136/thx.2004.028043

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  44 in total

1.  Goblet cell hyperplasia and epithelial inflammation in peripheral airways of smokers with both symptoms of chronic bronchitis and chronic airflow limitation.

Authors:  M Saetta; G Turato; S Baraldo; A Zanin; F Braccioni; C E Mapp; P Maestrelli; G Cavallesco; A Papi; L M Fabbri
Journal:  Am J Respir Crit Care Med       Date:  2000-03       Impact factor: 21.405

2.  Interleukin-9 upregulates mucus expression in the airways.

Authors:  J Louahed; M Toda; J Jen; Q Hamid; J C Renauld; R C Levitt; N C Nicolaides
Journal:  Am J Respir Cell Mol Biol       Date:  2000-06       Impact factor: 6.914

3.  The morphologic features of the bronchi, bronchioles, and alveoli in chronic airway obstruction: a clinicopathologic study.

Authors:  R S Mitchell; R E Stanford; J M Johnson; G W Silvers; G Dart; M S George
Journal:  Am Rev Respir Dis       Date:  1976-07

4.  Oxidative stress causes mucin synthesis via transactivation of epidermal growth factor receptor: role of neutrophils.

Authors:  K Takeyama; K Dabbagh; J Jeong Shim; T Dao-Pick; I F Ueki; J A Nadel
Journal:  J Immunol       Date:  2000-02-01       Impact factor: 5.422

5.  The relationship between airways inflammation and asthma severity.

Authors:  R Louis; L C Lau; A O Bron; A C Roldaan; M Radermecker; R Djukanović
Journal:  Am J Respir Crit Care Med       Date:  2000-01       Impact factor: 21.405

6.  Pathologic changes in the peripheral airways of young cigarette smokers.

Authors:  D E Niewoehner; J Kleinerman; D B Rice
Journal:  N Engl J Med       Date:  1974-10-10       Impact factor: 91.245

7.  Site and nature of airway obstruction in chronic obstructive lung disease.

Authors:  J C Hogg; P T Macklem; W M Thurlbeck
Journal:  N Engl J Med       Date:  1968-06-20       Impact factor: 91.245

Review 8.  The epidermal growth factor receptor and its ligand family: their potential role in repair and remodelling in asthma.

Authors:  D E Davies; R Polosa; S M Puddicombe; A Richter; S T Holgate
Journal:  Allergy       Date:  1999-08       Impact factor: 13.146

9.  Relationship between peripheral airway dysfunction, airway obstruction, and neutrophilic inflammation in COPD.

Authors:  R A O'Donnell; C Peebles; J A Ward; A Daraker; G Angco; P Broberg; S Pierrou; J Lund; S T Holgate; D E Davies; D J Delany; S J Wilson; R Djukanovic
Journal:  Thorax       Date:  2004-10       Impact factor: 9.139

10.  Genome-wide search and identification of a novel gel-forming mucin MUC19/Muc19 in glandular tissues.

Authors:  Yin Chen; Yu Hua Zhao; Tejas Baba Kalaslavadi; Edward Hamati; Keith Nehrke; Anh Dao Le; David K Ann; Reen Wu
Journal:  Am J Respir Cell Mol Biol       Date:  2003-07-25       Impact factor: 6.914

View more
  44 in total

Review 1.  Lung injury and lung cancer caused by cigarette smoke-induced oxidative stress: Molecular mechanisms and therapeutic opportunities involving the ceramide-generating machinery and epidermal growth factor receptor.

Authors:  Tzipora Goldkorn; Simone Filosto; Samuel Chung
Journal:  Antioxid Redox Signal       Date:  2014-07-01       Impact factor: 8.401

2.  MCP-1/CCR2B-dependent loop upregulates MUC5AC and MUC5B in human airway epithelium.

Authors:  Maria E Monzon; Rosanna Malbrán Forteza; S Marina Casalino-Matsuda
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-11-19       Impact factor: 5.464

3.  The role of the Akt/mTOR pathway in tobacco carcinogen-induced lung tumorigenesis.

Authors:  Regan M Memmott; Phillip A Dennis
Journal:  Clin Cancer Res       Date:  2009-12-22       Impact factor: 12.531

Review 4.  Lung injury and cancer: Mechanistic insights into ceramide and EGFR signaling under cigarette smoke.

Authors:  Tzipora Goldkorn; Simone Filosto
Journal:  Am J Respir Cell Mol Biol       Date:  2010-06-04       Impact factor: 6.914

Review 5.  Inflammatory cells in the airways in COPD.

Authors:  R O'Donnell; D Breen; S Wilson; R Djukanovic
Journal:  Thorax       Date:  2006-05       Impact factor: 9.139

6.  Use of a soluble epoxide hydrolase inhibitor in smoke-induced chronic obstructive pulmonary disease.

Authors:  Lei Wang; Jun Yang; Lei Guo; Dale Uyeminami; Hua Dong; Bruce D Hammock; Kent E Pinkerton
Journal:  Am J Respir Cell Mol Biol       Date:  2011-12-28       Impact factor: 6.914

7.  Cigarette smoke induces MUC5AC protein expression through the activation of Sp1.

Authors:  Y Peter Di; Jinming Zhao; Richart Harper
Journal:  J Biol Chem       Date:  2012-06-14       Impact factor: 5.157

Review 8.  Chronic bronchitis and chronic obstructive pulmonary disease.

Authors:  Victor Kim; Gerard J Criner
Journal:  Am J Respir Crit Care Med       Date:  2012-11-29       Impact factor: 21.405

9.  Src mediates cigarette smoke-induced resistance to tyrosine kinase inhibitors in NSCLC cells.

Authors:  Simone Filosto; David S Baston; Samuel Chung; Cathleen R Becker; Tzipora Goldkorn
Journal:  Mol Cancer Ther       Date:  2013-05-17       Impact factor: 6.261

10.  Assay of lapatinib in murine models of cigarette smoke carcinogenesis.

Authors:  Roumen Balansky; Alberto Izzotti; Francesco D'Agostini; Mariagrazia Longobardi; Rosanna T Micale; Sebastiano La Maestra; Anna Camoirano; Gancho Ganchev; Marietta Iltcheva; Vernon E Steele; Silvio De Flora
Journal:  Carcinogenesis       Date:  2014-07-22       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.